Eli Lilly

News

Lilly buys into psychedelics with $3.8bn AtaiBeckley deal

AtaiBeckley has been snapped up by Eli Lilly in a massive $3.8bn transaction that shows psychedelic drugs are now firmly in the pharma mainstream.

News

Lilly, Regeneron among firms chosen for FDA fast plant pilot

Eli Lilly, Regeneron, and five other drugmakers will take part in an FDA pilot designed to make it quicker and easier to set up manufacturing plants.

News

UK partners with Eli Lilly on obesity plan

The UK has teamed up with Eli Lilly on initiatives, backed with £85 million in funding, to expand access to treatment for obesity.

News

Lilly launches LillyDirect in the UK

Eli Lilly's LillyDirect, an important driver of sales of its weight-loss drugs in the US, has now arrived in the UK – with modifications.

News

Lilly trumpets strong result for Jaypirca in CLL at EHA

New data with Eli Lilly's Jaypirca at EHA 2026 has cemented its place as a second-line therapy for chronic lymphocytic leukaemia.

News

Basketball great Shaq fronts Lilly sleep apnoea campaign

Eli Lilly has recruited basketball legend Shaquille O'Neal to promote a sleep apnoea awareness campaign and make the case for treatment with Zepbound.

Lilly buys into psychedelics with $3.8bn AtaiBeckley deal

Lilly, Regeneron among firms chosen for FDA fast plant pilot

UK partners with Eli Lilly on obesity plan

Lilly launches LillyDirect in the UK

Lilly trumpets strong result for Jaypirca in CLL at EHA

Basketball great Shaq fronts Lilly sleep apnoea campaign

UK's Mission divests kidney drug to Dimerix for $292m

Discover a new era of healthcare panel engagement: Grounded ...

Eli Lilly

Editor's Picks